MARKET RADAR
SENSEX     NIFTY      Refresh
Moneycontrol.com India | Notes to Account > Pharmaceuticals > Notes to Account from Ivee Injecta - BSE: 530057, NSE: N.A
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > NOTES TO ACCOUNTS - Ivee Injecta
Ivee Injecta
BSE: 530057|ISIN: INE984E01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
23, :
27.20
0
VOLUME 0
Ivee Injecta is not listed on NSE
« Mar 11
Notes to Accounts Year End : Mar '12
1.  There is no movement of the shares outstanding at the beginning and
 at the end of the reporting period.
 
 2.  The Company has only one class of equity shares having a par value
 of Rs. 10 per share. Each shareholder is eligible for one vote per
 share. The dividend proposed by the Board of Directors is subject to
 the approval of shareholders, except in case of interim dividend in the
 event of liquidation, the equity shareholders are eligible to receive
 the remaining assets of the Company, after distribution of all
 preferential amounts, in proportion of their shareholding.
 
 3.  Company has not allotted any bonus shares, Shares without
 consideration in cash and/or bought back any equity shares during the
 period of five years immediately preceding the Balance sheet date.
 
 1 Sundry debtors over six months included Rs. 15,91,791/- being
 non-performing in nature. In the opinion of the Directors, they are
 good and recoverable. The Directors are hopeful of getting recoveries
 in the next year as the market conditions are not favorable. However
 in the opinion of the Auditors, it shall be prudent to identify the
 same as doubtful of recovery requiring adequate provision. It has been
 explained that the management of the company is pursuing recoveries and
 actual losses, if any, shall be adjusted as and when arises.
 
 2 In opinion of the management of the company, all loans, advances and
 deposits are recoverable in cash or kind for value to be received for
 which no provision is required. However in the opinion of the Auditors,
 it shall be prudent to make sufficient provision for such non
 performing assets amounting to Rs.  1,53,68,061/-.
 
 3 No Provision for gratuity and earned leave has been made in
 accordance with labour law consultant''s advice. Actuarial valuation in
 this regard is yet to be made.
 
 4 Contingent liabilities for claims against company not acknowledged
 and not provided for amounts to Rs.  5,01,271/- (P.Y. Rs. 5,01,271/-).
 As ascertained and certified by the management there is no other
 contingent liability for which provision is required.
 
 5 Balance of all personal accounts including Sundry debtors, Sundry
 creditors, Loans and Advances, Deposits etc. are subject to
 confirmation, reconciliation and appropriate adjustment.
 
 6.  During the year Management has written off Stock of Raw material
 and finished goods amounting to Rs.  504436/- and Live Stock of Rs.
 47880/- since no such assets were in existence and it is prudent to
 written off the same in the accounts.
 
 7 DISCLOSURE ON RELATED PARTIES:
 
 Name of the related parties & nature of the relationship
 
 A) Associate Company:
 
 1) M/s. Ivee Plasticaa (GUJ.) Pvt. Ltd.
 
 2) M/s. Nirman Infrastructure Ltd.
 
 In which our Director Dr. N. V. Vasavada is director. Inter corporate
 loan & advances given to them earlier which remains outstanding as on
 31.03.2012 Rs. 31,35,000/- maximum balance during the year Rs.
 31,35,000/- in opinion of auditor same is doubtful of recovery however
 the directors are hopeful of recovery.
 
 B) Key Management Person : 1) Mr. H. D. Nanavati – M.D.
 
 8.  Segment Report :
 
 The company is exclusively engaged in the business of manufacture and
 sale of Ivee fluids, Pharmaceuticals products in India and there is no
 other segmental activities hence no separate disclosure of reportable
 segment is required.
 
 9.  Earning & Expenditure in Foreign Currency : NIL
 
 10.  Previous year comparatives:
 
 Till the year ended 31st March, 2011, the Company was using pre-revised
 Schedule VI to the Companies Act, 1956, for preparation and
 presentation of its financial statements. During the year ended 31st
 March, 2012, the revised Schedule VI notified under the Companies Act,
 1956, has become applicable to the Company. The Company has
 reclassified previous year figures to conform to this year''s
 classification.
Source : Dion Global Solutions Limited
Quick Links for iveeinjecta
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.